IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Astellas Pharma Inc

CUSIP: 6985383 | 4 institutional holders

Quarters

Q3 2016Q2 2016Q1 2016Q4 2015Q3 2015
CompareDetailedHistoricalFundsOptions13D/13GPeersTargetingTrading SummaryProfile

Institutional Holders — Q3 2016

Boston Common Asset Management, LLC1,090,190
0.0% of portfolio›$16.9K
Paradigm Asset Management Co LLC4,000
0.0% of portfolio›$62.2K
StyleTurnoverLocationFiled
Boston Common Asset Management, LLC
1,090,190$16.9K0.0%CoreLowBoston, MA2016-11-04
Paradigm Asset Management Co LLC
4,000$62.2K0.0%GARPMediumNew York, NY2016-11-14